Evidence map›Paper›PMID 42290837›Full record

ArticleFrontiers in endocrinology2026

Factors associated with

Hongfang Liu, Hongxing Li, Xiaojuan Xu, Aiping Zhang, Bin Mao, Xiaoling Ma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hongfang LiuReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Hongxing LiReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Xiaojuan XuReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Aiping ZhangReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Bin MaoReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.
Xiaoling MaReproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Previous studies on factors influencing embryonic aneuploidy have produced inconsistent results. This study aimed to identify predictors of Methods: We analyzed associations between maternal age, paternal age, anti-Müllerian hormone (AMH), maternal body mass index (BMI), controlled ovarian stimulation (COS) protocol, sperm parameters, blastocyst expansion degree, inner cell mass (ICM) grade, trophectoderm (TE) grade, and Results: The incidence of Conclusion: In this study, advanced maternal age (≥35 years) emerged as a robust predictor of

Indexed as

AneuploidyGenetic TestingPreimplantation DiagnosisAdultAdvanced Maternal AgeAnti-Mullerian HormoneBlastocystFemaleFertilization in VitroHumansMaleMaternal AgePregnancyRetrospective StudiesAnti-Mullerian Hormoneaneuploidyanti-Müllerian hormone (AMH)blastocyst morphologypreimplantation genetic testingsemen parameters

Identifiers

PMID42290837
PMCPMC13253221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.